← Back to Search

Behavioral Intervention

Multi-component Intervention for Diabetes in Adults with Serious Mental Illness for Lifestyle Risk Reduction (MIDAS Trial)

N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 9 months and sustained at 15 months
Awards & highlights

MIDAS Trial Summary

This study is evaluating whether a lifestyle intervention can help reduce the risk of type 2 diabetes and premature mortality in individuals with serious mental illnesses.

Eligible Conditions
  • Diabetes
  • Lifestyle Risk Reduction
  • Serious Mental Illness
  • Schizophrenia
  • Obesity

MIDAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 9 months and sustained at 15 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 9 months and sustained at 15 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Mass Index (BMI in kg/m^2)
Fasting Glucose
Hemoglobin A1c or HbA1c
+1 more
Secondary outcome measures
Diet/Nutrition - Plasma Carotenoid Levels
Diet/Nutrition - Serum Lipid Levels
Objective Measure of Physical Activity
+2 more

MIDAS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention PhaseExperimental Treatment1 Intervention
6-month intervention phase - MIDAS Intervention Delivered. Followed by 6-month follow-up phase (no intervention, months 10-15).
Group II: Control PhaseActive Control1 Intervention
3-month initial control phase (no intervention, month 1-3)

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,123 Previous Clinical Trials
1,552,629 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~33 spots leftby May 2025